Atlas Trials

MyCustom:Prospective Master Protocol Trial on Precision Medicine Treatment for Refractory Solid Tumors

Clinical trial NCT06030869 · UNKNOWN

Trial details

NCT number
NCT06030869
Sponsor
Tianjin Medical University Second Hospital
Status
UNKNOWN
Study type
OBSERVATIONAL
Refractory Solid TumorsNext Generation Sequencing
Start date
2020-12-01
Primary completion
2023-12-30
Enrollment
400

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.